Navigation Links
Kensey Nash Reports Second Quarter Fiscal Year 2011 Financial Results
Date:2/1/2011

34,319,52238,812,450Operating costs and expenses:Cost of products sold

6,339,6966,491,98510,559,82112,030,385Research and development

3,969,7874,686,5158,247,1708,962,086Selling, general and administrative

2,065,6322,104,3074,363,5074,284,238Total operating costs and expenses

12,375,11513,282,80723,170,49825,276,709Income from operations

4,979,8085,787,82511,149,02413,535,741Interest and other (expense)/income, net

(292,027)(334,737)(647,980)(715,397)Pre-tax income

4,687,7815,453,08810,501,04412,820,344Income tax expense

1,354,1561,793,5593,322,5294,280,006Net income

$
3,333,625$
3,659,529$   7,178,515$   8,540,338Basic earnings per share

$
.39$
.33$
.82$
.77Diluted earnings per share

$
.38$
.32$
.79$
.75Weighted average common shares outstanding

8,511,33911,048,5328,774,48111,084,961Diluted weighted average common shares outstanding

8,816,75011,367,6739,035,54311,422,716CONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)December 31,June 30,20102010AssetsCurrent assets:Cash and cash equivalents

$
26,825,172$   23,102,362Investments

15,952,10642,571,544Trade receivables

4,521,9985,307,563Other receivables

6,302,8656,938,013Inventory

9,945,8698,885,875Prepaid expenses and other assets

3,019,1211,091,760Deferred tax asset, current

1,802,5262,857,262Total current assets

68,369,65790,754,379Property, plant and equipment, net

53,230,10654,984,890Deferred tax asset, non-current

1,539,9841,872,619Other non-current assets

10,080,4316,508,841Total assets

$  133,220,178$ 154,120,729Liabilities and Stockholders' Equity Current liabilities:Accounts payable and accrued expenses

$
3,760,000$
7,955,650Other current liabilities

230,457131,836Current portion of debt

1,399,9971,399,997Deferred revenue

1,047,321947,378Total
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
2. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
3. Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
4. Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
5. Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
6. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
7. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
8. Par Pharmaceutical Reports Second Quarter 2008 Results
9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
10. Pharmos Corporation Reports 2008 Second Quarter Results
11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Aug. 26, 2014 Trovagene, Inc. (NASDAQ: ... Dx Summit; Moving Assays to the Clinic ... Monitoring of Cell Free Tumor DNA in Urine." ... of its Precision Cancer Monitoring (PCM) platform and ... for the detection of tumor DNA mutations from ...
(Date:8/26/2014)... Aug. 26, 2014  That,s Nice LLC, a research-focused ... announced the formation of a new dedicated team that ... expanded team will combine current and new staff in ... Nice. Guy Tiene has ... the team. Tiene was previously Director of Marketing for ...
(Date:8/26/2014)... Boston, MA (PRWEB) August 26, 2014 ... to manage core research facilities , the ... of Kansas Cancer Center have chosen iLab Solutions' ... and effectively increase productivity. , "We are ... Center and KU Cancer Center signed on with ...
(Date:8/26/2014)... , Aug. 26, 2014 /PRNewswire-iReach/ -- The crowdfunding ... is in full effect on the popular crowdfunding platform ... their support for the biofeedback belt. The $75,000 funding ... mass-produce and distribute the product. Photo - ... small device worn on the lower back that silently ...
Breaking Biology Technology:Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3The University of Kansas Medical Center and The University of Kansas Cancer Center Select iLab Solutions Web-based Software to Streamline Operations 2The University of Kansas Medical Center and The University of Kansas Cancer Center Select iLab Solutions Web-based Software to Streamline Operations 3PosturePulse, A Biofeedback Posture-Improving Belt, Improves Posture While Sitting or Standing 2
... DIEGO -- In the Sept 9, 2010 issue of ... of concept studies that show its proprietary compound, NGP ... Alzheimer,s disease (AD) in a transgenic mouse model. ... the gamma secretase modulator (GSM) compound from NGP, the ...
... GAITHERSBURG, Md. Using a one-of-a-kind instrument designed and ... (NIST), an international team of researchers have "unveiled" a ... in graphene can split up into an unexpected and ... low temperatures and extremely high magnetic fields. Published in ...
... THE WOODLANDS, Texas, Sept. 9 Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... president and chief executive officer, will present at the ... 16, 2010 at 9:10 a.m. Eastern Time. ...
Cached Biology Technology:Neurogenetic studies show proprietary compound reduces brain plaques linked to Alzheimer's 2NIST researchers hear puzzling new physics from graphene quartet's quantum harmonies 2NIST researchers hear puzzling new physics from graphene quartet's quantum harmonies 3Lexicon to Present at Stifel Nicolaus Healthcare Conference 2
(Date:8/26/2014)... colony of harmful bacteria, biofilms make the treatment ... a biofilm pose a significant health risk due ... and biofilm-protected bacteria account for some 80 percent ... 50 to 1,000 times more resistant to antibiotics ... may have stumbled onto a magic bullet," said ...
(Date:8/26/2014)... Ill. University of Illinois engineers are bringing ... The researchers developed a new continuous glucose monitoring ... and the wavelength shift is so precise that ... it for automatic insulin dosing - something ... strips. , "There are significant limitations to current ...
(Date:8/26/2014)... at the University of Illinois at Urbana-Champaign have ... paving the way for power-on-a-chip applications. , ... scale that amplify light and produce ultra-narrowband spectral ... electrical and computer engineering (ECE) at Illinois. "These ... power on a chip containing both electronic and ...
Breaking Biology News(10 mins):Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3A glucose meter of a different color provides continuous monitoring 2A glucose meter of a different color provides continuous monitoring 3Symphony of nanoplasmonic and optical resonators produces laser-like light emission 2
... The efficacy of preimplantation genetic screening (PGS) has been ... over the past few years. None of the trials,carried ... or not. Now the European Society of Human,Reproduction and ... try to find out if a novel,method of doing ...
... what their football heroes can do with a football, the ... in excellent physical condition undoubtedly helps, few people actually believe ... into a Ronaldo. Now, scientists from the University of Queensland ... Dr. Robbie Wilson will talk about the details of this ...
... that the anti-malarial drug quinine can block a cell,s ... a discovery that may explain many of the adverse ... suggest that dietary tryptophan supplements could be a simple ... important drug. Quinine is a very commonly used ...
Cached Biology News:ESHRE launches international study of polar body screening 2What makes a great footballer? 2Tryptophan deficiency may underlie quinine side effects 2
ImageQuant 400, 1 EA. Category: ImageQuant CCD Imagers....
ImageQuant 100 UV, 1 EA. Category: ImageQuant CCD Imagers....
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
Recombinant Rat PTX2/SAP...
Biology Products: